Actively Recruiting
Evaluating 3D Imaging Technology for Detecting Advanced Adenomas During Colonoscopy A Multi-center Randomized Trial Comparing 3D and 2D Imaging Devices
Led by Xijing Hospital of Digestive Diseases · Updated on 2026-08-18
1566
Participants Needed
1
Research Sites
N/A
Total Duration
AI-Summary
What This Trial Is About
Researchers are evaluating a 3-dimensional 3D imaging device to see if it improves the detection of high-risk adenomas during colonoscopy compared to the standard 2-dimensional 2D imaging device. The study also aims to learn about the safety of using the 3D device by monitoring adverse events following colonoscopy. This trial is a multi-center randomized controlled study sponsored by Xijing Hospital of Digestive Diseases. Participants will undergo colonoscopy using either the 3D imaging colonoscope or the traditional 2D imaging colonoscope after bowel cleansing. The classification of detected lesions will be based on endoscopic diagnosis using the JNET classification system or pathological diagnosis from biopsy or polypectomy samples. The study compares the effectiveness and safety of these two imaging methods during colonoscopy. During the study, participants will be followed up for up to 30 days after the colonoscopy to record any related adverse events. Researchers will measure outcomes such as high-risk adenoma detection rate, adenoma detection rate, polyp detection rate, lesion detection rates by size and location, procedure times, and the number of lesions per colonoscopy. These assessments will help determine if the 3D imaging device improves detection while monitoring participant safety.
CONDITIONS
Brief Title
Advanced Adenoma Detection With 3D Imaging Device During Colonoscopy
Research Team
Z
zhiguo Liu, M.D
H
Hui Chen, M.D
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here